Celldex Therapeutics, Inc vs. Insight Molecular Diagnostics Inc. Common Stock
CLDX
Celldex Therapeutics, Inc
$39.94 -4.22%
VS IMDXInsight Molecular Diagnostics Inc. Common Stock
$4.30 -1.83%
Celldex Therapeutics, Inc and Insight Molecular Diagnostics Inc. Common Stock are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| CLDX | IMDX | |
|---|---|---|
| Market Cap | $3.27 billion | $143.33 million |
CLDX leads on 1 of 1 size & scale factors.
Risk & Sentiment
| CLDX | IMDX | |
|---|---|---|
| Short Interest | 9.28% | 0.93% |
IMDX leads on 1 of 1 risk & sentiment factors.
Dig deeper: CLDX overview, CLDX financials, IMDX overview, IMDX financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.